Peoples Financial Services Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Peoples Financial Services Corp’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.1K	Hold	50	–	–	0.01%	232
2026 Q1	$16.5K	Hold	50	–	–	0.01%	226
2025 Q4	$19.9K	Hold	50	–	–	0.01%	218
2025 Q3	$22.8K	Hold	50	–	–	0.01%	212
2025 Q2	$16.3K	Hold	50	–	–	0.01%	206
2025 Q1	$13.5K	Hold	50	–	–	0.01%	208
2024 Q4	$11.8K	Hold	50	–	–	0.01%	214
2024 Q3	$13.8K	Hold	50	–	–	0.01%	208
2024 Q2	$12.2K	Hold	50	–	–	0.01%	211
2024 Q1	$7.47K	Hold	50	–	–	﹤0.01%	221
2023 Q4	$9.57K	Hold	50	–	–	﹤0.01%	219
2023 Q3	$8.86K	Hold	50	–	–	﹤0.01%	223
2023 Q2	$9.5K	Hold	50	–	–	﹤0.01%	223
2023 Q1	$10K	Hold	50	–	–	﹤0.01%	221
2022 Q4	$11.9K	Hold	50	–	–	0.01%	215
2022 Q3	$10K	Hold	50	–	–	0.01%	223
2022 Q2	$7K	Hold	50	–	–	﹤0.01%	239
2022 Q1	$8K	Hold	50	–	–	﹤0.01%	242
2021 Q4	$8K	Hold	50	–	–	﹤0.01%	234
2021 Q3	$9K	Hold	50	–	–	﹤0.01%	231
2021 Q2	$8K	Hold	50	–	–	﹤0.01%	242
2021 Q1	$7K	Hold	50	–	–	﹤0.01%	238
2020 Q4	$6K	Hold	50	–	–	﹤0.01%	243
2020 Q3	$7K	Hold	50	–	–	﹤0.01%	220
2020 Q2	$7K	Hold	50	–	–	﹤0.01%	225
2020 Q1	$5K	Hold	50	–	–	﹤0.01%	245
2019 Q4	$6K	Hold	50	–	–	﹤0.01%	260
2019 Q3	$4K	Hold	50	–	–	﹤0.01%	290
2019 Q2	$4K	Hold	50	–	–	﹤0.01%	291
2019 Q1	$5K	Hold	50	–	–	﹤0.01%	273
2018 Q4	$4K	Hold	50	–	–	﹤0.01%	280
2018 Q3	$4K	Hold	50	–	–	﹤0.01%	299
2018 Q2	$5K	Buy	+50	New	+$4.96K	﹤0.01%	273

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Peoples Financial Services Corp's ALNY Position: Q2 2026 in Review

Peoples Financial Services Corp held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 50 shares worth $15.1K. The position accounts for 0.01% of the portfolio, ranked #232.

Peoples Financial Services Corp first reported a position in ALNY in Q2 2018 and has held it in 33 quarters since. The position peaked at $22.8K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Peoples Financial Services Corp held 50 shares of Alnylam Pharmaceuticals worth $15.1K as of Q2 2026.
Peoples Financial Services Corp left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
Alnylam Pharmaceuticals made up 0.01% of Peoples Financial Services Corp's portfolio in Q2 2026, its #232 holding.
Peoples Financial Services Corp first reported a position in Alnylam Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
Peoples Financial Services Corp's Alnylam Pharmaceuticals position peaked at $22.8K in Q3 2025.
790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Peoples Financial Services Corp's 13F filing for Q2 2026, filed 22 Jul 2026.